Effect of Colchicine on Progression of Known Coronary Atherosclerosis in Patients With Stable Coronary Artery Disease

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a randomized double-blind, placebo-controlled, investigator-initiated trial that compares Colchicine 0.5mg/day with placebo, among patients with stable CAD. Subjects will be educated to maintain medication compliance with other prescribed medications.
Epistemonikos ID: fb1dea52a7675b7a52b4557f234ae67379b5fb12
First added on: May 15, 2024